Tigermed
Huanyu (Harris) Tang is a Senior Business Development Manager at Tigermed since July 2022, previously serving as Business Development Manager and Team Leader of Technical Account Management at GenScript Europe from March 2017 to July 2022. In these roles, Huanyu managed accounts in the Nordic countries and Germany, overseeing a portfolio that included reagent services and CDMO services such as antibody drug discovery and gene therapy. Huanyu's experience also includes a position as Editor at Tencent from October 2013 to July 2017. Educationally, Huanyu holds a Master's degree in Microbiology from Nanjing Agricultural University (2014-2017) and a Bachelor's degree in Veterinary Medicine from the same institution (2009-2014).
This person is not in any teams
This person is not in any offices
Tigermed
1 followers
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 180 service locations, with over 10,000 employees across 50 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibilities for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.